Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1973 Oct 27;4(5886):185–186. doi: 10.1136/bmj.4.5886.185

Editorial: New vasodilator drugs for hypertension.

PMCID: PMC1587294  PMID: 4148460

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Wakim K. G., Worthington J. W., Ward L. E. Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore) 1967 Jan;46(1):1–33. doi: 10.1097/00005792-196701000-00001. [DOI] [PubMed] [Google Scholar]
  2. Clark D. W., Goldberg L. I. Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol. Ann Intern Med. 1972 Apr;76(4):579–585. doi: 10.7326/0003-4819-76-4-579. [DOI] [PubMed] [Google Scholar]
  3. EVANS D. A., DAVISON K., PRATT R. T. THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE. Clin Pharmacol Ther. 1965 Jul-Aug;6:430–435. doi: 10.1002/cpt196564430. [DOI] [PubMed] [Google Scholar]
  4. Gilmore E., Weil J., Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970 Mar 5;282(10):521–527. doi: 10.1056/NEJM197003052821001. [DOI] [PubMed] [Google Scholar]
  5. Gottlieb T. B., Katz F. H., Chidsey C. A., 3rd Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Circulation. 1972 Mar;45(3):571–582. doi: 10.1161/01.cir.45.3.571. [DOI] [PubMed] [Google Scholar]
  6. Hammer J., Ulrych M., Freis E. D. Hemodynamic and therapeutic effects of guancydine in hypertension. Clin Pharmacol Ther. 1971 Jan-Feb;12(1):78–90. doi: 10.1002/cpt197112178. [DOI] [PubMed] [Google Scholar]
  7. PAGE I. H., CORCORAN A. C., DUSTAN H. P., KOPPANYI T. Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation. 1955 Feb;11(2):188–198. doi: 10.1161/01.cir.11.2.188. [DOI] [PubMed] [Google Scholar]
  8. Pettinger W. A., Mitchell H. C. Minoxidil--an alternative to nephrectomy for refractory hypertension. N Engl J Med. 1973 Jul 26;289(4):167–171. doi: 10.1056/NEJM197307262890401. [DOI] [PubMed] [Google Scholar]
  9. Pohl J. E., Thurston H. Use of diazoxide in hypertension with renal failure. Br Med J. 1971 Oct 16;4(5780):142–145. doi: 10.1136/bmj.4.5780.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Seltzer H. S., Crout J. R. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas. Ann N Y Acad Sci. 1968 Apr 11;150(2):309–321. doi: 10.1111/j.1749-6632.1968.tb19056.x. [DOI] [PubMed] [Google Scholar]
  11. Zacest R., Gilmore E., Koch-Weser J. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. N Engl J Med. 1972 Mar 23;286(12):617–622. doi: 10.1056/NEJM197203232861201. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES